Clinical Efficacy of Combination of Sofosbuvir/velpatasvir and Ribavirin in CHC Patients with Cirrhosis and Its Influence on HCV-RNA Negative Conversion

TANG zhan-zhan

PDF(1809 KB)
KANGGANRAN YAOXUE
KANGGANRAN YAOXUE ›› 2021, Vol. 18 ›› Issue (6) : 917-919. DOI: 10.13493/j.issn.1672-7878.2021.06-042

Clinical Efficacy of Combination of Sofosbuvir/velpatasvir and Ribavirin in CHC Patients with Cirrhosis and Its Influence on HCV-RNA Negative Conversion

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 18(6): 917-919 https://doi.org/10.13493/j.issn.1672-7878.2021.06-042

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1809 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉